https://www.selleckchem.com/pr....oducts/donafenib-sor
The effect was similar in patients taking NSBBs for either primary or secondary oesophageal variceal prophylaxis and for those on NSBBs for other indications. Patients not on NSBBs had higher odds of infection (OR=2.5), SBP (OR=4., and bacteraemia (OR=6.. Home use of NSBBs by patients with cirrhosis was associated with fewer infection-related admissions. The data suggest that NSBBs in this group of patients reduce the risk of infection. Home use of NSBBs by patients with cirrhosis was associated with fewer infection-r
Like
Comment
Share
